Pfizer Deploys Pharmacovigilance Solution to US Market
MyMeds&Me, a SaaS provider of web-based adverse event and product quality complaint capture solutions for life sciences, announced the deployment of its Reportum® solution across all Pfizer safety call center sites in the United States.
MyMeds&Me, a SaaS provider of web-based adverse event and product quality complaint capture solutions for life sciences, announced the deployment of its Reportum® solution across all Pfizer safety call center sites in the United States. The Reportum® solution from MyMeds&Me will be Pfizer's standard for the U.S. Safety Call Center,and will support prompt availability of high quality safety data from reporters, including consumers, patients and healthcare professionals.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
